INITIAL PSA >=1.5 NG/ML IN MEN = < 50 YEARS OLD PREDICTS A SUBSEQUENT HIGHER RISK OF PROSTATE CANCER

被引：0
|
作者：
Uhlman, Matthew
Tang, Ping
Sun, Leon
Robertson, Cary
Polascik, Thomas
Albala, David
Donatucci, Craig
Moul, Judd
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.1572
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1724
引用
收藏
页码：E666 / E666
页数：1
相关论文
共 50 条
  • [31] The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4–10 ng/mL
    Xiang-Yi Zheng
    Li-Ping Xie
    Yu-Yong Wang
    Wei Ding
    Kai Yang
    Hua-Feng Shen
    Jie Qin
    Yu Bai
    Zhao-Dian Chen
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 1207 - 1210
  • [32] Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
    Thompson, IM
    Ankerst, DP
    Chi, C
    Lucia, MS
    Goodman, PJ
    Crowley, JJ
    Parnes, HL
    Coltman, CA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (01): : 66 - 70
  • [33] Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL
    Hong, Sung Kyu
    Oh, Jong Jin
    Byun, Seok-Soo
    Hwang, Sung Il
    Choo, Min Soo
    Lee, Sang Eun
    BJU INTERNATIONAL, 2012, 110 (2B) : E81 - E85
  • [34] Correlation of prostate volume and percent free PSA in prostate cancer detection in men with a total PSA 2.6-10.0 ng/ml
    Bruno, JJ
    Armenakas, NA
    Fracchia, JA
    JOURNAL OF UROLOGY, 2006, 175 (04): : 478 - 479
  • [35] Complexed PSA for early detection of prostate cancer in men with serum PSA levels of 2-4 ng/mL
    Bartsch, G
    Cheli, CD
    Horninger, W
    Babaian, RJ
    Fritsche, HA
    Lepor, H
    Taneja, S
    Childs, S
    Stamey, TA
    Sokoll, L
    Chan, D
    Brawer, MK
    Partin, AW
    JOURNAL OF UROLOGY, 2002, 167 (04): : 208 - 208
  • [36] Prostate cancer incidence and disease-specific survival in men participating in the ERSPC with an initial PSA less than 3.0 ng/mL
    Bul, M.
    van Leeuwen, P. J.
    Zhu, X.
    Schroder, F. H.
    Roobol, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [37] Association of Long-Term Dynamics in Circulating Testosterone with Serum PSA in Prostate Cancer-Free Men with Initial-PSA < 4 ng/mL
    Kai Wang
    Xinguang Chen
    Ting-Yuan David Cheng
    Peihua Qiu
    Victoria Y. Bird
    Mattia Prosperi
    Hormones and Cancer, 2019, 10 : 168 - 176
  • [38] Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng/ml
    Kravchick, S
    Peled, R
    Dorfman, D
    Agulansky, L
    Ben-Dor, D
    Cytron, S
    UROLOGY, 2005, 66 (03) : 542 - 546
  • [39] Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy
    Wu, Qiang
    Li, Fanglong
    Yin, Xiaotao
    Gao, Jiangping
    Zhang, Xu
    MEDICINE, 2021, 100 (50) : E28196
  • [40] Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1
    Wang, Cheng
    Wang, Yue-Yang
    Wang, Shi-Yuan
    Ding, Ji-Xiang
    Ding, Mao
    Ruan, Yuan
    Wang, Xiao-Hai
    Jing, Yi-Feng
    Han, Bang-Min
    Xia, Shu-Jie
    Jiang, Chen-Yi
    Zhao, Fu-Jun
    ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (04) : 415 - +
12345